Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...

In a further comparison using DPP-4i/SU as the reference, the GLP-1 RA/SGLT2i combination therapy had the greatest effect in ...

The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

EUR/USD rises as the US government shuts down and EZ inflation data is due. FTSE 100 hits fresh record highs, boosted by ...

The shares of GlaxoSmithKline ($GSK) cheered on Monday after the British pharmaceutical giant announced that its chief ...

Cerebras Systems' dinner plate-size chip technology has been a curiosity since the company introduced the Wafer Scale Engine ...

GSK named Luke Miels to succeed Emma Walmsley as the British drugmaker’s CEO. - chris j ratcliffe/Reuters GSK said Emma ...

Usman Azam, M.D., is appointed President and Chief Executive Officer of Cue Biopharma, effective September 29, 2025Daniel ...

Autism Research EXPERT Says Trump’s TYLENOL Claims ‘EXTREME’ & ‘DEVASTATING’ | SUNRISE The Trump administration is touting an old generic drug as a ...

Despite the new 100% US tariff on imported drugs, China’s biotech firms face minimal impact thanks to licensing deals and ...

Walmsley, who became CEO of the U.K. drugmaker in 2017 and is due to step down at the end of the year, led GSK through the Covid-19 pandemic, a fight with activist investor Elliott Management, and a ...

Trump announced another round of wide-ranging tariffs, sparking questions about their implications for consumers and businesses.